Filters
reset allOther countries
Results: 1 to 9 of 9
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
IDH1 and IDH2 Mutation Analysis PathGroup United States | 5 | 2 |
|
Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States | 3 | 1 |
|
Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States | 4 | 1 |
|
PrimBio Research Institute United States | 60 | 50 |
|
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece | 16 | 52 |
|
TERT Promoter Mutation Analysis Molecular Oncology Laboratory, LabCorp United States | 2 | 2 |
|
IDH1 and IDH2 Mutation Analysis Exon 4, Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 1 | 2 |
|
Molecular Oncology Laboratory, LabCorp United States | 2 | 2 |
|
IDH1 & IDH2 Hotspot Gene Panel Tissue Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic United States | 1 | 2 |
|
Results: 1 to 9 of 9
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.